Search hospitals > District of Columbia > Washington
Children's National Medical Center
Claim this profileWashington, District of Columbia 20010
Global Leader in Brain Tumor
Global Leader in Leukemia
Conducts research for Tumors
Conducts research for Recurrence
Conducts research for Solid Tumors
1070 reported clinical trials
71 medical researchers
Summary
Children's National Medical Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Brain Tumor, Leukemia, Tumors, Recurrence, Solid Tumors and other specialties. Children's National Medical Center is involved with conducting 1,070 clinical trials across 1,228 conditions. There are 71 research doctors associated with this hospital, such as Jeffrey S. Dome, AeRang Kim, MD, PhD, Eugene Hwang, MD, and Lindsay Kilburn, MD.Area of expertise
1Brain Tumor
Global LeaderStage IV
BRAF positive
Stage II
2Leukemia
Global LeaderCD19 positive
CD22 positive
Stage II
Top PIs
Jeffrey S. DomeChildren's National Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Cancer
64 reported clinical trials
112 drugs studied
AeRang Kim, MD, PhDChildren's National Medical Center6 years of reported clinical research
Expert in Tumors
Studies Sarcoma
20 reported clinical trials
32 drugs studied
Eugene Hwang, MDChildren's National Medical Center4 years of reported clinical research
Expert in Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
18 reported clinical trials
30 drugs studied
Lindsay Kilburn, MDChildren's National Medical Center5 years of reported clinical research
Studies Brain Tumor
Studies Recurrence
14 reported clinical trials
23 drugs studied
Clinical Trials running at Children's National Medical Center
Sickle Cell Anemia
Sickle Cell Disease
Brain Tumor
Low Grade Glioma
Astrocytoma
Polycystic Kidney Disease
Ovarian Tumors
Germ Cell Tumors
Cancer
Tumors
Bone Marrow Transplant
for Sickle Cell Disease
This study aims to enroll 58 pre-adolescent (\<13 years) pediatric participants with sickle cell disease (SCD) who have a pre-adolescent sibling bone marrow donor. All participants will go through a pre-transplant evaluation to find out if there are health problems that will keep them from being able to receive the transplant. It usually takes 2 to 3 months to complete the pre-transplant evaluation and make the arrangements for the transplant. Once they are found to be eligible for transplant, participants will be admitted to the hospital and will start transplant conditioning. Conditioning is the chemotherapy and other medicines given to prepare them to receive donor cells. It prevents the immune system from rejecting donor cells. Conditioning will start 21 days before transplant. Once they complete conditioning, participants will receive the bone marrow transplant. After the transplant, participants will stay in the hospital for 4-6 weeks. After they leave the hospital, participants will be followed closely in the clinic. Outpatient treatment and frequent clinic visits usually last 6 to 12 months. Routine medical care includes at least a yearly examination for many years after transplant by doctors and nurses familiar with sickle cell disease and transplant. The researchers will collect and study information about participants for 2 years after transplant.
Recruiting3 awards Phase 220 criteria
Crizanlizumab
for Sickle Cell Disease
This is a multi-center multi-national rollover study to allow continued access to crizanlizumab for patients with sickle cell disease (SCD) who are on crizanlizumab treatment in a Novartis-sponsored study (parent study) and are benefiting from the treatment as judged by the investigator.
Recruiting3 awards Phase 43 criteria
Gene Therapy
for Sickle Cell Disease
This is a non-randomized, open-label, multi-site, single-dose, Phase 3 study in approximately 35 adults and pediatric subjects ≥2 and ≤50 years of age with sickle cell disease (SCD). The study will evaluate hematopoietic stem cell (HSC) transplantation (HSCT) using bb1111 (also known as LentiGlobin BB305 Drug Product for SCD).
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's National Medical Center?
Children's National Medical Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Brain Tumor, Leukemia, Tumors, Recurrence, Solid Tumors and other specialties. Children's National Medical Center is involved with conducting 1,070 clinical trials across 1,228 conditions. There are 71 research doctors associated with this hospital, such as Jeffrey S. Dome, AeRang Kim, MD, PhD, Eugene Hwang, MD, and Lindsay Kilburn, MD.
Where is Children's National Medical Center located?
Children's National Medical Center is located at 111 Michigan Avenue NW, Washington, DC 20010. It is easily accessible by car and public transportation, with directions and information available on the hospital's website.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Children's National Medical Center, please call the Financial Information Center at 800-787-0021, option 6. If you have billing questions, reach out to the Customer Service Department at 301-572-3542. Our Customer Service Department is available Monday through Friday, from 9 a.m. to 4 p.m.
What insurance does Children's National Medical Center accept?
Children's National Medical Center accepts a wide range of insurance plans, including but not limited to Aetna Health Insurance, Blue Cross Blue Shield PPO/HMO, Cigna Healthcare, and United Healthcare. They do not accept certain commercial plans such as Blue Cross & Blue Shield PPO (alpha prefix NYC), Tricare West, and UHC – Empire, among others. Additionally, specific Medicaid (State) Plans and Healthy Kids Plans like Freedom, Molina, and Staywell are not accepted.
What awards or recognition has Children's National Medical Center received?
Children's National Medical Center, located in Washington, D.C., is globally recognized as the 14th best children's hospital by Newsweek and holds the #5 rank in the nation according to U.S. News & World Report. The hospital is a Magnet®-designated facility, acknowledging its excellence in nursing, and has been awarded for its efforts in reducing anesthetic gases. Additionally, it ranks 7th among pediatric institutions for National Institutes of Health (NIH) funding, showcasing a strong commitment to medical research.